NEB mutations disrupt the super-relaxed state of myosin and remodel the muscle metabolic proteome in nemaline myopathy

  • Aikaterini Kontrogianni-Konstantopoulos (Creator)
  • Justin Kolb (Creator)
  • Johanna Palmio (Creator)
  • Thomas Nyegaard Beck (Creator)
  • Maurizio Moggio (Creator)
  • Nanna Witting (Creator)
  • Nicol C. Voermans (Creator)
  • Edmar Zanoteli (Creator)
  • Chiara Fiorillo (Creator)
  • Mari Auranen (Creator)
  • Carina Wallgren-Pettersson (Creator)
  • Sanna Huovinen (Creator)
  • Natasha Ranu (Creator)
  • Hendrikus L Granzier (Creator)
  • Julien Ochala (Creator)
  • Jennifer Mariano (Creator)
  • John Vissing (Creator)

Dataset

Description

Abstract Nemaline myopathy (NM) is one of the most common non-dystrophic genetic muscle disorders. NM is often associated with mutations in the NEB gene. Even though the exact NEB-NM pathophysiological mechanisms remain unclear, histological analyses of patients’ muscle biopsies often reveal unexplained accumulation of glycogen and abnormally shaped mitochondria. Hence, the aim of the present study was to define the exact molecular and cellular cascade of events that would lead to potential changes in muscle energetics in NEB-NM. For that, we applied a wide range of biophysical and cell biology assays on skeletal muscle fibres from NM patients as well as untargeted proteomics analyses on isolated myofibres from a muscle-specific nebulin‐deficient mouse model. Unexpectedly, we found that the myosin stabilizing conformational state, known as super-relaxed state, was significantly impaired, inducing an increase in the energy (ATP) consumption of resting muscle fibres from NEB-NM patients when compared with controls or with other forms of genetic/rare, acquired NM. This destabilization of the myosin super-relaxed state had dynamic consequences as we observed a remodeling of the metabolic proteome in muscle fibres from nebulin‐deficient mice. Altogether, our findings explain some of the hitherto obscure hallmarks of NM, including the appearance of abnormal energy proteins and suggest potential beneficial effects of drugs targeting myosin activity/conformations for NEB-NM.
Date made available2024
Publisherfigshare

Cite this